These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26359119)

  • 1. Comparative Efficacy of Cardiac Resynchronization Therapy in Africans Americans Compared With European Americans.
    Rickard J; Baranowski B; Cheng A; Spragg D; Tedford R; Mukherjee M; Tang WH; Wilkoff BL; Varma N
    Am J Cardiol; 2015 Oct; 116(7):1101-5. PubMed ID: 26359119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.
    Rickard J; Johnston DR; Price J; Tedford R; Baranowski B; Bassiouny M; Cantillon D; Grimm RA; Tang WHW; Varma N; Wilkoff BL
    Heart Rhythm; 2015 Mar; 12(3):517-523. PubMed ID: 25460866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy.
    Rickard J; Bassiouny M; Tedford RJ; Baranowski B; Spragg D; Cantillon D; Varma N; Wilkoff BL; Tang WH
    Am J Cardiol; 2015 Jan; 115(1):82-5. PubMed ID: 25491007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic predictors of reverse remodeling after cardiac resynchronization therapy and subsequent events.
    Park JH; Negishi K; Grimm RA; Popovic Z; Stanton T; Wilkoff BL; Marwick TH
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):864-72. PubMed ID: 24084489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with heart failure and narrow QRS complexes (≤ 130 ms): role of speckle tracking echocardiography and different interventricular (VV) pacing intervals.
    Kantharia BK; Singh A; Narasimhan B; Wu L; Karnik R; Chutani S; Shah AN
    J Interv Card Electrophysiol; 2022 Mar; 63(2):369-377. PubMed ID: 34138397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced left ventricular mechanical dispersion at 6 months follow-up after cardiac resynchronization therapy is associated with superior long-term outcome.
    van der Bijl P; Khidir MJH; Leung M; Yilmaz D; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Heart Rhythm; 2018 Nov; 15(11):1683-1689. PubMed ID: 29753023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy.
    Cikes M; Sanchez-Martinez S; Claggett B; Duchateau N; Piella G; Butakoff C; Pouleur AC; Knappe D; Biering-Sørensen T; Kutyifa V; Moss A; Stein K; Solomon SD; Bijnens B
    Eur J Heart Fail; 2019 Jan; 21(1):74-85. PubMed ID: 30328654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.
    Skaf S; Thibault B; Khairy P; O'Meara E; Fortier A; Vakulenko HV; Pitre C; White M; Ducharme A;
    Can J Cardiol; 2017 Oct; 33(10):1274-1282. PubMed ID: 28941607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
    Dreger H; Borges AC; Baumann G; Melzer C
    Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
    Rickard J; Bassiouny M; Cronin EM; Martin DO; Varma N; Niebauer MJ; Tchou PJ; Tang WH; Wilkoff BL
    Am J Cardiol; 2011 Dec; 108(11):1576-80. PubMed ID: 21890086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for cardiac resynchronization therapy response: the importance of QRS morphology and left ventricular lead position.
    Lin H; Zhou Y; Xu G
    Int Heart J; 2014; 55(3):256-63. PubMed ID: 24806381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.
    Gopinathannair R; Roukoz H; Bhan A; Ravichandran A; Ahmed MM; Familtsev D; Bhat G; Cowger J; Abdullah M; Sandesara C; Dhawan R; Birks EJ; Trivedi JR; Slaughter MS
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Size does not Modify the Effect of QRS Duration in Predicting Response to Cardiac Resynchronization Therapy.
    Rickard J; Baranowski B; Grimm RA; Niebauer M; Varma N; Tang WHW; Wilkoff BL
    Pacing Clin Electrophysiol; 2017 May; 40(5):482-487. PubMed ID: 28164328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy.
    Shamoun F; De Marco T; DeMets D; Mei C; Lindenfeld J; Saxon LA; Boehmer JP; Leigh J; Yong P; Feldman AM; Bristow MR
    JACC Heart Fail; 2019 Apr; 7(4):281-290. PubMed ID: 30738980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.